13F-HR/A filed by Eversept Partners, LP
Eversept Partners, LP filed this 13F-HR/A for the quarter ended 2022-12-31, filed 2023-11-08, with 64 holding rows worth $1,141,557,026.
- Accession
- 0001697013-23-000033
- Filer
- CIK 1697013
- Filed
- 2023-11-08
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2022
A holdings report, amendment of type restatement, 64 entries on the cover page, a total value of $1,141,557,026 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,141,557,026 with VALUE read as dollars as filed, 13F file number 028-18369. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| GSK PLC SPONSORED ADR | 37733W204 | ADR | 3,490,457 | $123,825,940 | dollars as filed | |
| HORIZON THERAPEUTICS PLC | G46188101 | SHS | 1,064,446 | $121,133,955 | dollars as filed | |
| NATERA INC COM | 632307104 | Stock | 2,685,959 | $107,894,973 | dollars as filed | |
| SANOFI SA SPONSORED ADR | 80105N105 | ADR | 1,603,348 | $77,650,144 | dollars as filed | |
| GSK PLC SPONSORED ADR | 37733W204 | ADR | 2,093,700 | $73,572,618 | dollars as filed | call |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 232,787 | $64,735,737 | dollars as filed | |
| Danaher Corporation | 235851102 | COM | 162,571 | $43,189,420 | dollars as filed | |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 4,712,597 | $42,978,885 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 1,620,713 | $41,247,146 | dollars as filed | |
| BIOGEN INC COM | 09062X103 | Stock | 137,348 | $38,034,408 | dollars as filed | |
| CATALENT INC USD 0.01 | 148806102 | COM | 691,677 | $31,132,382 | dollars as filed | |
| ILLUMINA INC | 452327109 | COM | 140,067 | $28,321,547 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 558,774 | $24,904,557 | dollars as filed | |
| ENVISTA HOLDINGS CORPORATION | 29415F104 | COM | 642,405 | $21,629,776 | dollars as filed | |
| SPDR SER TR | 78464A870 | S&P BIOTECH | 216,087 | $17,935,221 | dollars as filed | |
| CENTENE CORP DEL COM | 15135B101 | Stock | 214,561 | $17,596,148 | dollars as filed | |
| HALEON PLC SPON ADS | 405552100 | ADR | 1,881,470 | $15,051,760 | dollars as filed | |
| ELEVANCE HEALTH INC FORMERLY | 036752903 | CALL | 28,042 | $14,384,705 | dollars as filed | |
| ICON PUB LTD CO SHS | G4705A100 | Stock | 66,693 | $12,955,115 | dollars as filed | |
| AVANTOR INC COM | 05352A100 | Stock | 600,200 | $12,658,218 | dollars as filed | |
| TENET HEALTHCARE CORP COM NEW | 88033G407 | Stock | 254,586 | $12,421,251 | dollars as filed | |
| SERES THERAPEUTICS INC | 81750R102 | COM | 2,200,999 | $12,325,594 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 275,704 | $10,871,009 | dollars as filed | |
| HUMANA INC COM | 444859102 | Stock | 20,911 | $10,726,489 | dollars as filed | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 880,487 | $10,107,991 | dollars as filed | |
| REPLIGEN CORP COM | 759916109 | Stock | 57,004 | $9,651,347 | dollars as filed | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 240,975 | $9,101,626 | dollars as filed | |
| MODEL N INC | 607525102 | COM | 217,880 | $8,837,213 | dollars as filed | |
| COMMUNITY HEALTH SYSTEMS INC | 203668108 | COMMON STOCK | 2,001,994 | $8,648,614 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 178,453 | $8,556,821 | dollars as filed | |
| LIQUIDIA CORPORATION COM NEW | 53635D202 | Stock | 1,290,913 | $8,223,116 | dollars as filed | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 154,796 | $8,004,501 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 411,308 | $7,958,810 | dollars as filed | |
| IVERIC BIO INC | 46583P102 | COM | 350,747 | $7,509,493 | dollars as filed | |
| SPDR SER TR | 78464A870 | S&P BIOTECH | 90,000 | $7,470,000 | dollars as filed | call |
| TARO PHARMACEUTICAL INDS LTD | M8737E108 | SHS | 225,462 | $6,547,416 | dollars as filed | |
| PUMA BIOTECHNOLOGY INC | 74587V107 | COMMON STOCK | 1,507,663 | $6,377,414 | dollars as filed | |
| Merck & Co.,Inc. | 58933Y105 | COM | 48,700 | $5,403,265 | dollars as filed | call |
| EVOLUS INC | 30052C107 | COM | 713,774 | $5,360,443 | dollars as filed | |
| INCYTE CORP COM | 45337C102 | Stock | 63,996 | $5,140,159 | dollars as filed | |
| GUARDANT HEALTH INC COM | 40131M109 | Stock | 146,129 | $3,974,709 | dollars as filed | |
| AMARIN CORPORATION PLC -ADR | 023111906 | ADR | 3,284,114 | $3,973,778 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 184,556 | $2,855,081 | dollars as filed | |
| AEROVATE THERAPEUTICS INC | 008064107 | COM | 91,252 | $2,673,684 | dollars as filed | |
| PLIANT THERAPEUTICS INC | 729139105 | COM | 137,423 | $2,656,387 | dollars as filed | |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 282,874 | $2,616,585 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 185,595 | $2,576,059 | dollars as filed | |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 272,900 | $2,488,848 | dollars as filed | call |
| IQVIA HLDGS INC COM | 46266C105 | Stock | 10,889 | $2,231,047 | dollars as filed | |
| AGILENT TECHNOLOGIES INC COM | 00846U101 | Stock | 11,878 | $1,780,215 | dollars as filed | |
| AMNEAL PHARMACEUTICALS INC | 03168L105 | COM STK CL A | 830,960 | $1,653,610 | dollars as filed | |
| XOMA ROYALTY CORPORATION | 98419J206 | COMMON STOCK | 86,873 | $1,598,463 | dollars as filed | |
| REVVITY INC | 714046109 | COM | 11,178 | $1,567,379 | dollars as filed | |
| BIO-TECHNE CORP | 09073M104 | COM | 16,635 | $1,378,709 | dollars as filed | |
| COMMUNITY HEALTH SYSTEMS INC | 203668108 | COMMON STOCK | 312,900 | $1,351,728 | dollars as filed | call |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 3,476 | $1,316,813 | dollars as filed | |
| WHITEHAWK THERAPEUTICS INC | 00032Q104 | CMN | 101,918 | $1,307,608 | dollars as filed | |
| HESKA CORP | 42805E306 | COM | 19,475 | $1,210,566 | dollars as filed | |
| GOHEALTH INC | 38046W204 | CL A NEW | 50,522 | $527,955 | dollars as filed | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 43,562 | $439,541 | dollars as filed | |
| AFFIMED N V | N01045108 | COM | 330,224 | $409,478 | dollars as filed | |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 154,212 | $334,640 | dollars as filed | |
| GLYCOMIMETICS INC | 38000Q102 | COM | 100,579 | $304,754 | dollars as filed | |
| AC IMMUNE SA | H00263105 | SHS | 124,589 | $254,162 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001655789-23-000002 | superseded | 2023-02-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001697013-23-000033 | this filing | 2023-11-08 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001697013-23-000034 | added | 2023-11-08 | acceptance time not in the bulk data set |